These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 32065226)
1. Prognostic impact of circumferential resection margin in esophageal cancer with or without neoadjuvant chemoradiotherapy. Liu CY; Hsu PK; Hsu HS; Wu YC; Chuang CY; Lin CH; Hsu CP Dis Esophagus; 2020 Sep; 33(9):. PubMed ID: 32065226 [TBL] [Abstract][Full Text] [Related]
2. Prognostic Value of the Circumferential Resection Margin in Esophageal Cancer Patients After Neoadjuvant Chemoradiotherapy. Hulshoff JB; Faiz Z; Karrenbeld A; Kats-Ugurlu G; Burgerhof JG; Smit JK; Plukker JT Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1301-9. PubMed ID: 26314875 [TBL] [Abstract][Full Text] [Related]
3. The prognostic significance of the positive circumferential resection margin in pathologic T3 squamous cell carcinoma of the esophagus with or without neoadjuvant chemotherapy. Okada N; Fujii S; Fujita T; Kanamori J; Kojima T; Hayashi R; Daiko H Surgery; 2016 Feb; 159(2):441-50. PubMed ID: 26391150 [TBL] [Abstract][Full Text] [Related]
4. Prognostic value of the circumferential resection margin and its definitions in esophageal cancer patients after neoadjuvant chemoradiotherapy. Depypere L; Moons J; Lerut T; De Hertogh G; Peters C; Sagaert X; Coosemans W; Van Veer H; Nafteux P Dis Esophagus; 2018 Feb; 31(2):. PubMed ID: 29036407 [TBL] [Abstract][Full Text] [Related]
5. The prognostic value of circumferential resection margin in esophageal squamous cell carcinoma after concurrent chemoradiation therapy and surgery. Liu CY; Wang BY; Lee MY; Tsai YC; Liu CC; Shih CH J Chin Med Assoc; 2013 Oct; 76(10):570-5. PubMed ID: 23938149 [TBL] [Abstract][Full Text] [Related]
6. Morbidity and Mortality of Patients Who Underwent Minimally Invasive Esophagectomy After Neoadjuvant Chemoradiotherapy vs Neoadjuvant Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Randomized Clinical Trial. Wang H; Tang H; Fang Y; Tan L; Yin J; Shen Y; Zeng Z; Zhu J; Hou Y; Du M; Jiao J; Jiang H; Gong L; Li Z; Liu J; Xie D; Li W; Lian C; Zhao Q; Chen C; Zheng B; Liao Y; Li K; Li H; Wu H; Dai L; Chen KN JAMA Surg; 2021 May; 156(5):444-451. PubMed ID: 33729467 [TBL] [Abstract][Full Text] [Related]
7. Comparison of neoadjuvant chemotherapy versus upfront surgery with or without chemotherapy for patients with clinical stage III esophageal squamous cell carcinoma. Matsuda S; Tsubosa Y; Sato H; Takebayashi K; Kawamorita K; Mori K; Niihara M; Tsushima T; Yokota T; Onozawa Y; Yasui H; Takeuchi H; Kitagawa Y Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 26919154 [TBL] [Abstract][Full Text] [Related]
8. The prognostic significance of the circumferential resection margin in esophageal squamous cell carcinoma patients without neoadjuvant treatment. Yang Z; Lin H; Wang Z; Rong L; Zhang X; Wang L; Qin J; Xue X; Li Y; Xue L BMC Cancer; 2022 Nov; 22(1):1180. PubMed ID: 36384463 [TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant Chemoradiation Versus Upfront Esophagectomy in Clinical Stage II and III Esophageal Squamous Cell Carcinoma. Hsu PK; Chen HS; Liu CC; Wu SC Ann Surg Oncol; 2019 Feb; 26(2):506-513. PubMed ID: 30430325 [TBL] [Abstract][Full Text] [Related]
10. Prognostic Impact of Inflammation-Based Factors in Patients with Esophageal Squamous Cell Carcinoma Achieving Pathological Complete Response After Neoadjuvant Chemoradiotherapy Followed by Surgery. Kim JY; Yun JK; Kim YH; Park SI; Lee JH; Jung HY; Lee GH; Song HJ; Kim DH; Choi KD; Ahn JY; Kim SB; Cho KJ; Ryu JS; Kim JH; Kang J; Park SR; Kim HR Ann Surg Oncol; 2024 Oct; 31(10):6662-6672. PubMed ID: 38954089 [TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for the treatment of esophageal squamous cell carcinoma: a propensity score-matched study from the National Cancer Center in China. Zhang G; Zhang C; Sun N; Xue L; Yang Z; Fang L; Zhang Z; Luo Y; Gao S; Xue Q; Mu J; Gao Y; Tan F; He J J Cancer Res Clin Oncol; 2022 Apr; 148(4):943-954. PubMed ID: 34013382 [TBL] [Abstract][Full Text] [Related]
12. Long-term Efficacy of Neoadjuvant Chemoradiotherapy Plus Surgery for the Treatment of Locally Advanced Esophageal Squamous Cell Carcinoma: The NEOCRTEC5010 Randomized Clinical Trial. Yang H; Liu H; Chen Y; Zhu C; Fang W; Yu Z; Mao W; Xiang J; Han Y; Chen Z; Yang H; Wang J; Pang Q; Zheng X; Yang H; Li T; Zhang X; Li Q; Wang G; Chen B; Mao T; Kong M; Guo X; Lin T; Liu M; Fu J JAMA Surg; 2021 Aug; 156(8):721-729. PubMed ID: 34160577 [TBL] [Abstract][Full Text] [Related]
13. Validation of the post-neoadjuvant staging system of the American joint committee on cancer, 8th edition, in patients treated with neoadjuvant chemoradiotherapy followed by curative esophagectomy for localized esophageal squamous cell carcinoma. Kang J; Lee HP; Kim HR; Kim JH; Jung HY; Lee GH; Song HJ; Kim DH; Choi KD; Ahn JY; Ryu JS; Cho KJ; Lee MY; Kim SB; Kim YH; Park SR Surg Oncol; 2020 Dec; 35():491-497. PubMed ID: 33130441 [TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant chemotherapy combined with immunotherapy versus neoadjuvant chemoradiotherapy in patients with locally advanced esophageal squamous cell carcinoma. Yu YK; Meng FY; Wei XF; Chen XK; Li HM; Liu Q; Li CJ; Xie HN; Xu L; Zhang RX; Xing W; Li Y J Thorac Cardiovasc Surg; 2024 Aug; 168(2):417-428.e3. PubMed ID: 38246339 [TBL] [Abstract][Full Text] [Related]
15. Prognostic role of initial pan-endoscopic tumor length at diagnosis in operable esophageal squamous cell carcinoma undergoing esophagectomy with or without neoadjuvant concurrent chemoradiotherapy. Lin CS; Liu CY; Cheng CT; Tsai YC; Chiou LW; Lee MY; Liu CC; Shih CH J Thorac Dis; 2017 Sep; 9(9):3193-3207. PubMed ID: 29221296 [TBL] [Abstract][Full Text] [Related]
16. Identification of Optimal Parameters for Assessing Lymph Node Status of Patients with Esophageal Squamous Cell Carcinoma After Neoadjuvant Chemoradiotherapy. Huang X; Jiang D; Jian Z; Zeng Z; Zhang S; Fan H; Sun T; Tang H; Hou Y; Tan L Ann Surg Oncol; 2024 Feb; 31(2):883-891. PubMed ID: 38038788 [TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy followed by minimally invasive esophagectomy for locally advanced esophageal squamous cell carcinoma: a prospective multicenter randomized clinical trial. Tang H; Wang H; Fang Y; Zhu JY; Yin J; Shen YX; Zeng ZC; Jiang DX; Hou YY; Du M; Lian CH; Zhao Q; Jiang HJ; Gong L; Li ZG; Liu J; Xie DY; Li WF; Chen C; Zheng B; Chen KN; Dai L; Liao YD; Li K; Li HC; Zhao NQ; Tan LJ Ann Oncol; 2023 Feb; 34(2):163-172. PubMed ID: 36400384 [TBL] [Abstract][Full Text] [Related]
18. Effects of Neoadjuvant Chemoradiotherapy on Pathological TNM Stage and Their Prognostic Significance for Surgically-treated Esophageal Squamous Cell Carcinoma. Hamai Y; Hihara J; Emi M; Furukawa T; Ibuki Y; Yamakita I; Kurokawa T; Okada M Anticancer Res; 2017 Oct; 37(10):5639-5646. PubMed ID: 28982881 [TBL] [Abstract][Full Text] [Related]
19. Survival Comparison Among Neoadjuvant Chemoradiotherapy Followed by Esophagectomy, Definitive Chemoradiotherapy, and Esophagectomy Alone for Esophageal Squamous Cell Carcinoma. Chen HS; Lin CH; Wu SC; Wang BY Ann Surg Oncol; 2022 Jun; 29(6):3617-3627. PubMed ID: 34994899 [TBL] [Abstract][Full Text] [Related]
20. Reduction in chemotherapy relative dose intensity decreases overall survival of neoadjuvant chemoradiotherapy in patients with locally advanced esophageal carcinoma. Jiang L; Zhu J; Chen X; Wang Y; Wu L; Wan G; Han Y; Leng X; Zhang J; Peng L; Wang Q BMC Cancer; 2024 Aug; 24(1):945. PubMed ID: 39095767 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]